We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks to Watch. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other stocks featured in Jim Cramer’s Lightning Round.
Jim Cramer, the host of Mad Money, recently offered his views on several key topics, including Big Tech stocks and cryptocurrency. On the subject of Big Tech, Cramer advised investors not to write off the mega-cap companies, especially after some of them saw gains toward the end of November, following declines. He stressed that moments like these serve as a reminder of what happens when people lose faith in these companies. Cramer explained:
“Remember it because it’s a textbook reminder of what happens when you decide the mega capitalization stocks are done, when you think that they’re written off. The moment you give up on them, what happens? They come roaring back.”
READ ALSO Jim Cramer Thinks These 13 Stocks Will Benefit From the New Administration and Jim Cramer’s List of 7 Energy Stocks for the Trump Trade
Cramer also reiterated his long-standing support for cryptocurrency, framing it as a potential hedge against the government’s growing deficit and the risk of inflation. While acknowledging that there is no clear evidence yet that crypto can effectively shield against economic challenges, he suggested that it remains a plausible option for many investors.
“I’ve liked crypto for a very long time, mostly because I know there’s a huge constituency of investors who want to buy something that can protect them from our government’s busted budget.”
He added that, although crypto’s ability to offer protection is unproven, “sometimes that’s all you need in this business.” Reflecting on the country’s fiscal outlook, Cramer expressed hope that the U.S. economy might eventually grow its way out of the deficit through higher tax receipts. However, he fears that political gridlock, particularly during debt ceiling debates, could lead to drastic measures, such as the government buying back treasury bonds at a discount.
Cramer also expressed disappointment in both the Obama and Trump administrations for failing to issue long-term, 50-year treasury bonds during periods of ultra-low interest rates. He described this decision as a missed opportunity that would have saved the government substantial amounts of money. Instead, Cramer noted that the government now finds itself issuing short-term debt at much higher rates, which he deemed a mistake.
